如何展示药物诱发的 1 型 Brugada 模式心电图。

IF 2.2 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Naoya Kataoka MD, Teruhiko Imamura MD, PhD
{"title":"如何展示药物诱发的 1 型 Brugada 模式心电图。","authors":"Naoya Kataoka MD,&nbsp;Teruhiko Imamura MD, PhD","doi":"10.1002/joa3.13170","DOIUrl":null,"url":null,"abstract":"<p>Data on drug-induced Type 1 Brugada patterns remain limited. The authors' study examined the clinical characteristics and implications of drug-induced Type 1 Brugada patterns,<span><sup>1</sup></span> raising several concerns.</p><p>During the follow-up period, 10% of patients exhibited a spontaneous Type 1 pattern,<span><sup>1</sup></span> suggesting that Brugada syndrome may be a progressive disease. Recently, multiple syndromes, including Brugada syndrome, J-wave syndrome, and idiopathic ventricular fibrillation, have been postulated to represent the same underlying condition: subepicardial cardiomyopathy.<span><sup>2</sup></span> This condition is characterized by an arrhythmogenic substrate located in the epicardium with fibrosis and the progressive nature of Brugada syndrome lends support to this concept. Another critical concern is the identification of patients in whom a spontaneous Type 1 pattern develops. This cohort may demonstrate a higher prevalence of pathogenic variants and delayed enhancement on cardiac magnetic resonance imaging. The prognostic significance of these findings remains a topic of interest.</p><p>Due to the small number of events observed in patients with drug-induced Type 1 patterns, the authors did not advocate for routine sodium channel blocker challenge tests.<span><sup>1</sup></span> However, the underlying mechanisms responsible for these findings remain unclear. The sodium channel blocker challenge test is typically performed to identify arrhythmogenic substrates, which are the therapeutic targets of catheter ablation in symptomatic Brugada syndrome patients.<span><sup>3</sup></span> Should we reconsider the necessity of this drug challenge test to ensure adequate catheter ablation?</p><p>The authors' study did not address the presence of early repolarization,<span><sup>1</sup></span> which is often seen in patients with Brugada syndrome and constitutes a risk factor for arrhythmic events.<span><sup>4</sup></span> How many patients had concomitant early repolarization? The response to ajmaline in J-wave may vary depending on the presence of arrhythmic events or the specific location of early repolarization, an aspect that warrants further investigation.</p><p>Authors declare no conflict of interests for this article.</p>","PeriodicalId":15174,"journal":{"name":"Journal of Arrhythmia","volume":"40 6","pages":"1535"},"PeriodicalIF":2.2000,"publicationDate":"2024-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11632267/pdf/","citationCount":"0","resultStr":"{\"title\":\"How to demonstrate drug-induced Type 1 Brugada pattern electrocardiogram\",\"authors\":\"Naoya Kataoka MD,&nbsp;Teruhiko Imamura MD, PhD\",\"doi\":\"10.1002/joa3.13170\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Data on drug-induced Type 1 Brugada patterns remain limited. The authors' study examined the clinical characteristics and implications of drug-induced Type 1 Brugada patterns,<span><sup>1</sup></span> raising several concerns.</p><p>During the follow-up period, 10% of patients exhibited a spontaneous Type 1 pattern,<span><sup>1</sup></span> suggesting that Brugada syndrome may be a progressive disease. Recently, multiple syndromes, including Brugada syndrome, J-wave syndrome, and idiopathic ventricular fibrillation, have been postulated to represent the same underlying condition: subepicardial cardiomyopathy.<span><sup>2</sup></span> This condition is characterized by an arrhythmogenic substrate located in the epicardium with fibrosis and the progressive nature of Brugada syndrome lends support to this concept. Another critical concern is the identification of patients in whom a spontaneous Type 1 pattern develops. This cohort may demonstrate a higher prevalence of pathogenic variants and delayed enhancement on cardiac magnetic resonance imaging. The prognostic significance of these findings remains a topic of interest.</p><p>Due to the small number of events observed in patients with drug-induced Type 1 patterns, the authors did not advocate for routine sodium channel blocker challenge tests.<span><sup>1</sup></span> However, the underlying mechanisms responsible for these findings remain unclear. The sodium channel blocker challenge test is typically performed to identify arrhythmogenic substrates, which are the therapeutic targets of catheter ablation in symptomatic Brugada syndrome patients.<span><sup>3</sup></span> Should we reconsider the necessity of this drug challenge test to ensure adequate catheter ablation?</p><p>The authors' study did not address the presence of early repolarization,<span><sup>1</sup></span> which is often seen in patients with Brugada syndrome and constitutes a risk factor for arrhythmic events.<span><sup>4</sup></span> How many patients had concomitant early repolarization? The response to ajmaline in J-wave may vary depending on the presence of arrhythmic events or the specific location of early repolarization, an aspect that warrants further investigation.</p><p>Authors declare no conflict of interests for this article.</p>\",\"PeriodicalId\":15174,\"journal\":{\"name\":\"Journal of Arrhythmia\",\"volume\":\"40 6\",\"pages\":\"1535\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2024-10-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11632267/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Arrhythmia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/joa3.13170\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Arrhythmia","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/joa3.13170","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

关于药物诱导的1型Brugada模式的数据仍然有限。作者的研究检查了药物诱导的1型Brugada模式的临床特征和影响,提出了几个问题。在随访期间,10%的患者表现为自发性1型,1提示Brugada综合征可能是一种进行性疾病。最近,包括Brugada综合征、j波综合征和特发性心室颤动在内的多种综合征被认为代表了相同的潜在疾病:心外膜下心肌病这种疾病的特点是心外膜内有致心律失常底物并伴有纤维化,Brugada综合征的进行性支持了这一概念。另一个关键的问题是确定自发性1型模式发展的患者。该队列可能显示出较高的致病变异患病率和心脏磁共振成像延迟增强。这些发现的预后意义仍然是一个有趣的话题。由于在药物诱导的1型患者中观察到的事件很少,作者不提倡常规的钠通道阻滞剂激发试验然而,导致这些发现的潜在机制仍不清楚。钠通道阻滞剂激发试验通常用于识别致心律失常底物,这是症状性Brugada综合征患者导管消融的治疗靶点我们是否应该重新考虑这种药物激发试验的必要性,以确保充分的导管消融?作者的研究没有涉及早期复极的存在,这在Brugada综合征患者中很常见,是心律失常事件的一个危险因素有多少患者伴有早期复极?j波对ajmaline的反应可能因心律失常事件的存在或早期复极的特定位置而异,这方面值得进一步研究。作者声明本文无利益冲突。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
How to demonstrate drug-induced Type 1 Brugada pattern electrocardiogram

Data on drug-induced Type 1 Brugada patterns remain limited. The authors' study examined the clinical characteristics and implications of drug-induced Type 1 Brugada patterns,1 raising several concerns.

During the follow-up period, 10% of patients exhibited a spontaneous Type 1 pattern,1 suggesting that Brugada syndrome may be a progressive disease. Recently, multiple syndromes, including Brugada syndrome, J-wave syndrome, and idiopathic ventricular fibrillation, have been postulated to represent the same underlying condition: subepicardial cardiomyopathy.2 This condition is characterized by an arrhythmogenic substrate located in the epicardium with fibrosis and the progressive nature of Brugada syndrome lends support to this concept. Another critical concern is the identification of patients in whom a spontaneous Type 1 pattern develops. This cohort may demonstrate a higher prevalence of pathogenic variants and delayed enhancement on cardiac magnetic resonance imaging. The prognostic significance of these findings remains a topic of interest.

Due to the small number of events observed in patients with drug-induced Type 1 patterns, the authors did not advocate for routine sodium channel blocker challenge tests.1 However, the underlying mechanisms responsible for these findings remain unclear. The sodium channel blocker challenge test is typically performed to identify arrhythmogenic substrates, which are the therapeutic targets of catheter ablation in symptomatic Brugada syndrome patients.3 Should we reconsider the necessity of this drug challenge test to ensure adequate catheter ablation?

The authors' study did not address the presence of early repolarization,1 which is often seen in patients with Brugada syndrome and constitutes a risk factor for arrhythmic events.4 How many patients had concomitant early repolarization? The response to ajmaline in J-wave may vary depending on the presence of arrhythmic events or the specific location of early repolarization, an aspect that warrants further investigation.

Authors declare no conflict of interests for this article.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Arrhythmia
Journal of Arrhythmia CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
2.90
自引率
10.00%
发文量
127
审稿时长
45 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信